Similarly, the binding of SETD2 to TP53 can modulate the expression of a specific set of TP53 downstream target genes, including the apoptosis-related genes puma, noxa, and p53AIP1, which are relevant to cancer development [55]. The gene discussed is SETD2; the disease is cancer.